High competition drives innovation by pushing researchers to explore novel approaches and technologies. This includes the development of [targeted therapies](), [immunotherapies](), and [personalized medicine](). The race to be the first to publish new findings or bring a new drug to market accelerates the pace of discovery and development. Collaboration and data sharing among competitive entities can also lead to synergistic advancements.
